An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study
Clinical trial NCT01588184 · COMPLETED
Trial details
- NCT number
- NCT01588184
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-13
- Primary completion
- 2019-09-27
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.